Search research articles
Contact Us
Filters
Showing results (281-290 of 393) with videos related to
Page
of 40
Sort By:
ESMO Open
|
August 28, 2020
Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study
Anastasia Constantinidou, Nicolas Sauve, Silvia Stacchiotti, et al.
Future Oncology (London, England)
|
September 4, 2024
The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with <i>KIT</i> exon 11 + 17/18 mutations
Suzanne George, Jean-Yves Blay, Ping Chi, et al.
Nature Medicine
|
October 12, 2023
Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors
César Serrano, Sara Rothschild, Guillermo Villacampa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 30, 2018
Desmoid fibromatosis through the patients' eyes: time to change the focus and organisation of care?
Olga Husson, Eugenie Younger, Alison Dunlop, et al.
The Oncologist
|
September 12, 2020
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid Tumors
Spyridon Gennatas, Florence Chamberlain, Alannah Smrke, et al.
Clinical Sarcoma Research
|
May 12, 2020
Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern Ireland
Spyridon Gennatas, Florence Chamberlain, Thomas Carter, et al.
Bone & Joint Open
|
April 2, 2026
Optimal clinical management of tenosynovial giant cell tumours: a UK perspective
, Sydney Stern, Robert Ashford, et al.
Cancer Medicine
|
May 7, 2021
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer
Robin L Jones, Thomas J Herzog, Shreyaskumar R Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2022
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma
Michael J Wagner, Yuzheng Zhang, Lee D Cranmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2020
Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib
Filip Janku, Albiruni R Abdul Razak, Ping Chi, et al.
Page
of 40
Search research articles
Search
Showing results (281-290 of 393) with videos related to
Sort By:
Page
of 40
ESMO Open
|
August 28, 2020
Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study
Anastasia Constantinidou, Nicolas Sauve, Silvia Stacchiotti, et al.
Future Oncology (London, England)
|
September 4, 2024
The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with <i>KIT</i> exon 11 + 17/18 mutations
Suzanne George, Jean-Yves Blay, Ping Chi, et al.
Nature Medicine
|
October 12, 2023
Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors
César Serrano, Sara Rothschild, Guillermo Villacampa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 30, 2018
Desmoid fibromatosis through the patients' eyes: time to change the focus and organisation of care?
Olga Husson, Eugenie Younger, Alison Dunlop, et al.
The Oncologist
|
September 12, 2020
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid Tumors
Spyridon Gennatas, Florence Chamberlain, Alannah Smrke, et al.
Clinical Sarcoma Research
|
May 12, 2020
Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern Ireland
Spyridon Gennatas, Florence Chamberlain, Thomas Carter, et al.
Bone & Joint Open
|
April 2, 2026
Optimal clinical management of tenosynovial giant cell tumours: a UK perspective
, Sydney Stern, Robert Ashford, et al.
Cancer Medicine
|
May 7, 2021
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer
Robin L Jones, Thomas J Herzog, Shreyaskumar R Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2022
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma
Michael J Wagner, Yuzheng Zhang, Lee D Cranmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2020
Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib
Filip Janku, Albiruni R Abdul Razak, Ping Chi, et al.
Page
of 40